<DOC>
	<DOC>NCT00174447</DOC>
	<brief_summary>Open label extension study of Ziprasidone, evaluation of safety of long term use of ziprasidone</brief_summary>
	<brief_title>Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Patients who successfully completed study A1281031 (CGI score of 1 or 2 at final visit) or ZIPNY98035 and with QTc &lt;= 500 msec. All other patients who do not fit the inclusion criteria as stated above.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>